Capstone Investment Advisors LLC Makes New Investment in Chemed Corporation $CHE

Capstone Investment Advisors LLC bought a new position in shares of Chemed Corporation (NYSE:CHE) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 1,175 shares of the company’s stock, valued at approximately $547,000.

A number of other large investors have also recently made changes to their positions in the stock. Quantbot Technologies LP purchased a new position in Chemed during the 2nd quarter valued at about $1,726,000. TD Asset Management Inc grew its holdings in Chemed by 7.5% in the fourth quarter. TD Asset Management Inc now owns 324,546 shares of the company’s stock worth $138,860,000 after purchasing an additional 22,715 shares during the period. BNP Paribas Financial Markets grew its holdings in Chemed by 14.5% in the fourth quarter. BNP Paribas Financial Markets now owns 35,024 shares of the company’s stock worth $14,985,000 after purchasing an additional 4,430 shares during the period. Epoch Investment Partners Inc. increased its stake in shares of Chemed by 4.9% during the fourth quarter. Epoch Investment Partners Inc. now owns 322,408 shares of the company’s stock valued at $137,945,000 after purchasing an additional 15,133 shares in the last quarter. Finally, C WorldWide Group Holding A S bought a new position in shares of Chemed during the fourth quarter valued at approximately $2,189,000. 95.85% of the stock is owned by hedge funds and other institutional investors.

Chemed Trading Up 0.6%

Shares of NYSE CHE opened at $523.57 on Friday. The firm’s 50 day moving average price is $509.45 and its 200-day moving average price is $449.67. Chemed Corporation has a 52-week low of $365.20 and a 52-week high of $557.00. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.89 and a current ratio of 0.91. The company has a market cap of $6.84 billion, a PE ratio of 26.30, a P/E/G ratio of 1.97 and a beta of 0.51.

Chemed (NYSE:CHE) last announced its quarterly earnings results on Tuesday, July 28th. The company reported $6.06 earnings per share for the quarter, beating the consensus estimate of $5.60 by $0.46. Chemed had a net margin of 10.60% and a return on equity of 31.77%. The company had revenue of $673.25 million during the quarter, compared to the consensus estimate of $665.04 million. During the same quarter last year, the firm earned $4.27 earnings per share. The firm’s quarterly revenue was up 8.8% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. On average, equities research analysts expect that Chemed Corporation will post 23.18 EPS for the current fiscal year.

Chemed Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 3rd. Shareholders of record on Monday, August 17th will be issued a $0.70 dividend. This represents a $2.80 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date of this dividend is Monday, August 17th. This is a positive change from Chemed’s previous quarterly dividend of $0.60. Chemed’s dividend payout ratio is 14.06%.

Analysts Set New Price Targets

A number of analysts have recently commented on the company. Wall Street Zen raised Chemed from a “hold” rating to a “strong-buy” rating in a research report on Saturday, August 1st. Weiss Ratings upgraded Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, July 17th. Bank of America reissued a “neutral” rating on shares of Chemed in a report on Wednesday, July 29th. Oppenheimer increased their target price on Chemed from $500.00 to $590.00 and gave the stock an “outperform” rating in a research note on Friday, July 31st. Finally, Royal Bank Of Canada lifted their price target on Chemed from $436.00 to $548.00 and gave the stock a “sector perform” rating in a research report on Thursday, July 30th. One analyst has rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $530.75.

Insiders Place Their Bets

In related news, Director Patrick P. Grace sold 190 shares of the stock in a transaction on Friday, July 31st. The stock was sold at an average price of $532.00, for a total transaction of $101,080.00. Following the sale, the director directly owned 3,533 shares of the company’s stock, valued at $1,879,556. This trade represents a 5.10% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction dated Monday, August 3rd. The stock was sold at an average price of $539.51, for a total value of $1,079,020.00. Following the completion of the sale, the chief executive officer owned 70,418 shares of the company’s stock, valued at $37,991,215.18. The trade was a 2.76% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 6,537 shares of company stock worth $3,406,014 over the last three months. Company insiders own 3.33% of the company’s stock.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.